熱門資訊> 正文

Olema Oncology任命Jason O ' Byrne为CFO

2026-08-13 21:25

Olema Pharmaceuticals (OLMA) has appointed Jason O’Byrne as chief financial officer.
O’Byrne brings more than two decades of finance and global operations leadership across high-growth biotechnology and pharmaceutical organizations, the company said. He joins Olema from Vir Biotechnology, where he served as executive vice president and chief financial officer, leading the finance, investor relations, and information technology functions.
OLMA +2.3% to $10.68.
Source: Press Release

More on Olema Pharmaceuticals

Olema Pharmaceuticals, Inc. (OLMA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Olema: The Market Overreacted To Roche's SERD Failure
Seeking Alpha’s Quant Rating on Olema Pharmaceuticals
Historical earnings data for Olema Pharmaceuticals
Financial information for Olema Pharmaceuticals

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。